Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$8.5 - $10.38 $193,800 - $236,664
22,800 Added 1.44%
1,611,388 $14.7 Million
Q1 2023

May 12, 2023

BUY
$7.53 - $10.95 $928,245 - $1.35 Million
123,273 Added 8.41%
1,588,588 $15 Million
Q4 2022

Feb 09, 2023

BUY
$9.44 - $13.09 $107,672 - $149,304
11,406 Added 0.78%
1,465,315 $14.6 Million
Q3 2022

Nov 09, 2022

SELL
$8.14 - $12.25 $1.51 Million - $2.27 Million
-184,996 Reduced 11.29%
1,453,909 $17.3 Million
Q2 2022

Aug 10, 2022

BUY
$6.99 - $10.0 $72,954 - $104,370
10,437 Added 0.64%
1,638,905 $13.4 Million
Q1 2022

May 11, 2022

BUY
$7.26 - $10.7 $255,414 - $376,436
35,181 Added 2.21%
1,628,468 $12.9 Million
Q4 2021

Feb 14, 2022

BUY
$8.8 - $16.0 $3.29 Million - $5.99 Million
374,221 Added 30.7%
1,593,287 $14.9 Million
Q3 2021

Nov 10, 2021

SELL
$15.23 - $21.72 $2.88 Million - $4.11 Million
-189,109 Reduced 13.43%
1,219,066 $19.3 Million
Q2 2021

Aug 12, 2021

SELL
$17.8 - $23.5 $1.01 Million - $1.34 Million
-56,872 Reduced 3.88%
1,408,175 $30.4 Million
Q1 2021

May 13, 2021

BUY
$17.18 - $22.6 $1.95 Million - $2.56 Million
113,276 Added 8.38%
1,465,047 $29.7 Million
Q4 2020

Feb 09, 2021

BUY
$11.5 - $17.96 $950,889 - $1.49 Million
82,686 Added 6.52%
1,351,771 $24.2 Million
Q3 2020

Nov 06, 2020

BUY
$10.62 - $13.12 $2.91 Million - $3.59 Million
273,590 Added 27.48%
1,269,085 $14.8 Million
Q2 2020

Aug 12, 2020

SELL
$7.35 - $10.81 $310,941 - $457,317
-42,305 Reduced 4.08%
995,495 $9.2 Million
Q1 2020

May 08, 2020

BUY
$8.38 - $17.34 $969,741 - $2.01 Million
115,721 Added 12.55%
1,037,800 $10.8 Million
Q4 2019

Feb 12, 2020

BUY
$11.18 - $18.6 $2.35 Million - $3.9 Million
209,811 Added 29.46%
922,079 $16.5 Million
Q3 2019

Nov 12, 2019

BUY
$12.09 - $20.46 $2.79 Million - $4.73 Million
230,987 Added 47.99%
712,268 $8.89 Million
Q2 2019

Aug 09, 2019

BUY
$18.5 - $25.47 $8.9 Million - $12.3 Million
481,281 New
481,281 $9.53 Million
Q3 2018

Nov 13, 2018

SELL
$34.05 - $55.9 $6.99 Million - $11.5 Million
-205,280 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$36.15 - $52.5 $2.16 Million - $3.14 Million
-59,879 Reduced 22.58%
205,280 $10.3 Million
Q1 2018

May 14, 2018

BUY
$24.4 - $40.25 $2.09 Million - $3.45 Million
85,609 Added 47.68%
265,159 $9.68 Million
Q4 2017

Feb 14, 2018

BUY
$18.5 - $28.6 $3.32 Million - $5.14 Million
179,550
179,550 $5.08 Million

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $661M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track William Blair Investment Management, LLC Portfolio

Follow William Blair Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of William Blair Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on William Blair Investment Management, LLC with notifications on news.